Waltham, MA - Digoxin use is linked to mortality in patients with end-stage renal disease (ESRD), according to the results of a retrospective cohort study reported online June 24, 2010 in the Journal ...

Digoxin, originally derived from the foxglove flower, blocks the sodium/potassium ATPase pump. The mechanism by which this decreases atrioventricular (AV) conduction is not clear, butperhaps it is due ...

In patients with heart failure with reduced ejection fraction (HFrEF) who have an implantable cardioverter-defibrillator (ICD), the use of digoxin may increase the risk of ventricular tachyarrhythmia ...

Patients with atrial fibrillation (AFib) who are given digoxin to control their symptoms have an increased risk of death, whether or not they have a diagnosis of heart failure, compared with patients ...

Digoxin, a cardiac glycoside derived from the foxglove plant, has been a mainstay of treatment in systolic heart failure and in rate control for atrial fibrillation. By inhibiting the cardiac ...

A sensitive (0.2 ng per milliliter), precise (standard deviation 3 to 4 per cent), and specific radioimmunoassay for serum digoxin concentration has been developed. Levels are determined by ...

NEW ORLEANS, LA—Treating patients with symptomatic rheumatic heart disease (RHD) with digoxin appears to modestly reduce the risk of all-cause mortality or new-onset or worsening heart failure (HF), ...

Digoxin is a medication used to help treat heart failure and heartbeat irregularities. Your digoxin levels tell you the amount of digoxin that is in your body at a certain time. Having too much or too ...

A proof-of-concept trial by researchers at ETH Zurich, the University Hospitals of Basel and Zurich, and the Basel-Land Cantonal Hospital, demonstrated that treating breast cancer patients with a low, ...